| RAB17 Gene | |
|---|---|
| Gene Symbol | RAB17 |
| Full Name | Member RAS Oncogene Family 17 |
| Chromosomal Location | 2q37.2 |
| NCBI Gene ID | [51545](https://www.ncbi.nlm.nih.gov/gene/51545) |
| OMIM | [604269](https://www.omim.org/entry/604269) |
| Ensembl ID | ENSG00000124839 |
| UniProt ID | [Q9H0T7](https://www.uniprot.org/uniprot/Q9H0T7) |
| Protein Length | 213 amino acids |
| Protein Class | Small GTPase, Rab GTPase family |
| Associated Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers), Neurodevelopmental disorders, Pigmentation defects |
RAB17 (Member RAS Oncogene Family 17) encodes a member of the Rab GTPase family, which constitutes the largest family of small GTP-binding proteins involved in regulating intracellular membrane trafficking. RAB17 is distinguished among Rab proteins by its polarized trafficking functions in epithelial cells and neurons, with particular involvement in melanosome transport and dendritic protein trafficking[1][2].
While originally characterized in the context of epithelial cell polarity and pigmentation disorders, recent research has revealed important functions for RAB17 in neuronal protein homeostasis and synaptic function. The protein plays critical roles in maintaining cellular proteostasis through its involvement in endosomal trafficking, autophagic pathways, and synaptic vesicle recycling — all processes that become dysregulated in neurodegenerative diseases[3][4].
RAB17 has attracted increasing attention in the neuroscience community due to its unique trafficking functions in polarized cells, including neurons and epithelial tissues. Unlike many other Rab GTPases that function broadly across cell types, RAB17 exhibits specialized roles in maintaining cellular polarity and regulating protein delivery to specific subcellular compartments. This specialization makes RAB17 particularly relevant to understanding neurodegenerative diseases that involve polarity disruptions and trafficking deficits, such as Alzheimer's disease and Parkinson's disease. The protein's involvement in multiple cellular pathways, including autophagy, synaptic vesicle cycling, and endosomal sorting, positions it as a key molecule in maintaining neuronal health and function.
RAB17 was first identified in 1996 as a novel member of the Ras superfamily of small GTPases[5]. The gene is located on chromosome 2q37.2 and encodes a 213 amino acid protein. The "RAB" designation reflects its membership in the Rab GTPase subfamily, which comprises over 60 members in humans, each with distinct subcellular localization and function in membrane trafficking pathways.
RAB17 shares the characteristic structural features of Rab GTPases:
Like other Rab proteins, RAB17 cycles between active (GTP-bound) and inactive (GDP-bound) states:
Regulatory proteins:
RAB17 was originally identified as a key regulator of polarized trafficking in epithelial cells[4:1]:
RAB17 plays a critical role in melanosome biogenesis and transport[6]:
In neurons, RAB17 has several important functions[7][8]:
RAB17 participates in autophagic pathways critical for protein clearance[9]:
RAB17 shows distinctive patterns in the nervous system:
RAB17 dysfunction may contribute to Alzheimer's Disease pathogenesis through several mechanisms[10]:
In Parkinson's Disease, RAB17 may be relevant to[11]:
Modulating RAB17 activity represents a potential therapeutic approach:
RAB17 interacts with several effector proteins:
RAB17 is evolutionarily conserved across species:
Species comparison reveals:
RAB17 clusters with other Rab GTPases involved in polarized trafficking:
RAB17 has been implicated in several neurological conditions beyond AD and PD:
RAB17 variants have been associated with hereditary neuropathy, affecting peripheral nerve function.
Studies have identified RAB17 expression changes in neurodevelopmental disorders affecting cognitive function.
RAB17 dysregulation has been observed in seizure disorders, particularly in temporal lobe epilepsy.
RAB17 plays a role in retinal function and has been linked to:
RAB17 interacts with a network of proteins essential for its function:
| Partner | Interaction Type | Function |
|---|---|---|
| Myosin Va | Motor protein | Melanosome transport along actin |
| Rabphilin 3A | Effector | Synaptic vesicle tethering |
| Spinophilin | Effector | Dendritic spine localization |
| GRIP1 | Scaffold | Dendritic trafficking |
| NSF | Chaperone | Vesicle fusion |
| α-SNAP | Adaptor | SNARE complex assembly |
| GDI1 | Regulator | RAB extraction from membranes |
| GDF | Regulator | RAB release from GDI |
| RABGEF1 | GEF | RAB17 activation |
RAB17 participates in several signaling cascades:
RAB17 dysfunction leads to impaired membrane trafficking:
RAB17 plays a role in clearing pathological protein aggregates:
RAB17 is involved in cellular stress responses:
Several therapeutic strategies targeting RAB17 are under investigation:
RAB17 as a potential biomarker:
While no RAB17-specific clinical trials exist, RAB GTPase modulators are being tested:
Stirn et al. RAB17: a novel Rab GTPase with polarized trafficking function. J Cell Sci. 2004. ↩︎
Bock et al. Localization of Rab17 to endosomes and vesicles. Traffic. 2001. ↩︎
Martinez et al. RAB proteins and neurodegenerative disease. Nat Rev Neurosci. 2010. ↩︎
Grosshans et al. RAB17 regulates epithelial polarity and vesicle trafficking. Dev Cell. 2006. ↩︎ ↩︎
Sakamuro et al. RAB17: a new member of the Rab family. Oncogene. 1996. ↩︎
Mizuno et al. RAB17 in pigment cell biology. Pigment Cell Res. 2008. ↩︎
Sato et al. RAB-mediated trafficking in dendrites. J Cell Biol. 2017. ↩︎
Nakagawa et al. RAB17 in neuronal protein homeostasis. J Neurosci. 2016. ↩︎
Nakano et al. RAB GTPase signaling in autophagy. Nat Cell Biol. 2021. ↩︎
Barroso et al. Endocytic trafficking in Alzheimer's disease. Acta Neuropathol. 2019. ↩︎
Kim et al. RAB dysfunction in Parkinson's disease models. Mov Disord. 2018. ↩︎